Inhalation Sciences Sweden AB Stock NORDIC GROWTH MARKET
Stocks
ISAB
SE0009983893
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
NORDIC GROWTH MARKET
31/01/2024
|
5-day change | 1st Jan Change | ||
| 4.340 SEK | +6.90% |
|
-.--% | - |
| 09-22 | Inhalation Sciences ends M&A process, changes CEO | FW |
| 08-28 | Inhalation Sciences receives SEK 0.5m from warrants | FW |
| Market Cap | 4.15M 413K 367K 343K 312K 589K 39.72M 595K 1.61M 20.31M 1.55M 1.52M 65.18M | P/E 2024 |
-12.8x | P/E 2025 | -12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.32M 131K 117K 109K 99.12K 187K 12.61M 189K 510K 6.44M 492K 482K 20.68M | EV / Sales 2024 |
5.6x | EV / Sales 2025 | 55x |
| Free-Float |
99.4% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +6.90% |
| Manager | Title | Age | Since |
|---|---|---|---|
Manoush Masarrat
CEO | Chief Executive Officer | - | 16/09/2019 |
Per Magnus Gerde
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2005 |
Ulf Wedenberg
PRN | Corporate Officer/Principal | - | 02/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Per Magnus Gerde
BRD | Director/Board Member | - | 01/01/2005 |
Jan Hellqvist
BRD | Director/Board Member | - | 01/09/2022 |
Ulf Ericsson
BRD | Director/Board Member | - | 01/09/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.90% | -.--% | - | - | 413K | |
| +0.15% | -3.09% | +24.60% | +31.93% | 241B | |
| +1.69% | -4.12% | +2.34% | +0.71% | 149B | |
| -1.53% | -2.46% | -10.79% | +33.98% | 142B | |
| -0.45% | -2.08% | -55.31% | -18.57% | 62.65B | |
| +0.34% | -1.04% | +11.40% | +23.43% | 49.1B | |
| +0.66% | +0.19% | -19.29% | -21.24% | 47.13B | |
| +0.55% | -3.06% | +20.77% | +51.05% | 46.99B | |
| -2.75% | -2.14% | -8.68% | +36.53% | 45.65B | |
| -0.04% | -1.73% | +32.34% | +57.49% | 41.81B | |
| Average | +0.56% | +0.29% | -0.29% | +21.70% | 91.69B | |
| Weighted average by Cap. | -0.01% | +0.45% | +3.48% | +21.91% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 11.05M 1.1M 978K 913K 832K 1.57M 106M 1.58M 4.28M 54.1M 4.13M 4.04M 174M | 3.04M 303K 269K 251K 229K 432K 29.13M 436K 1.18M 14.89M 1.14M 1.11M 47.79M |
| Net income | -5.15M -513K -456K -425K -388K -731K -49.3M -738K -1.99M -25.2M -1.93M -1.88M -80.89M | -10.16M -1.01M -900K -840K -765K -1.44M -97.32M -1.46M -3.94M -49.75M -3.8M -3.72M -160M |
| Net Debt | -4M -399K -354K -331K -301K -569K -38.35M -574K -1.55M -19.6M -1.5M -1.47M -62.91M | -2.83M -282K -251K -234K -213K -402K -27.12M -406K -1.1M -13.86M -1.06M -1.04M -44.49M |
Employees
-
Net sales - Rate of surprise
- Stock Market
- Stocks
- ISAB Stock
- ISAB Stock
Select your edition
All financial news and data tailored to specific country editions
